University Of California, Davis
Clinical trials sponsored by University Of California, Davis, explained in plain language.
-
New Pill-and-Infusion combo shows promise for lymphoma patients
Disease control TerminatedThis study tested a combination of two drugs—lenalidomide (a pill) and rituximab (an infusion)—in 30 adults with untreated, slow-growing non-Hodgkin's lymphoma. The goal was to see how well the treatment shrinks or eliminates cancer. Participants took lenalidomide daily for three…
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 27, 2026 11:51 UTC
-
Promising prostate cancer drug trial halted early
Disease control TerminatedThis study tested the drug niraparib in men with high-risk prostate cancer that had not spread. The drug targets tumors with specific DNA repair problems. Only 11 men enrolled before the study was stopped early. The goal was to see if the drug could shrink or eliminate tumors bef…
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 22, 2026 13:51 UTC